EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Evaluation of Organic and Organometallic Pyrazoline Derivatives as Selective Dual COX-2/5-LOX Inhibitors and Potential Anticancer Agents

Elizabeth Navarrete iD, Tomás Cáceres M iD, Pilar Morales, Michelle Muñoz-Osses, Olivier Blacque iD, Pierre Mesdom, Kevin Cariou, Fernando Godoy iD, Gilles Gasser iD, Erick Flores iD, Carolina Mascayano

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.5c02815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Elizabeth Navarrete und 10 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciencias del Ambiente, Universidad de Santiago de Chile, Santiago 9170022, Chile. Hauptthemen laut MEDLINE: Pyrazoles, Antineoplastic Agents, Drug Design, Cyclooxygenase 2 Inhibitors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: Departamento de Investigaciones Cient?ficas y Tecnol?gicas, Universidad de Santiago de Chile, Fondo Nacional de Desarrollo Cient?fico y Tecnol?gico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inspired by the structure of the anti-inflammatory drug Celecoxib, which is currently used in cancer prevention and treatment, we report the design, synthesis, and biological evaluation of organic and organometallic molecular hybrids based on pyrazolines ( 4a – h ). Structure–Activity Relationship (SAR) analyses showed that the combination of catechol-benzenesulfonamide in 4a (organic) and 4c (ferrocenyl) derivatives acts as potent and highly selective dual inhibitors (IC 50 COX-2 = 4.58 and 2.88 μM; IC 50 5-LOX = 0.23 and 0.10 μM, respectively; evaluated against COX-1 and 15-LOX isoforms). Molecular dynamics simulations of 4a and 4c in 5-LOX showed their preferential localization at the allosteric site and at the entry channel, respectively, consistent with their noncompetitive ( 4a ) and mixed ( 4c ) kinetics. Furthermore, the noncytotoxic complex 4c (MRC-5, CC 50 = 38.13 μM) exhibited anticancer effects in ovarian cancer cells (A2780, CC 50 = 13.79 μM) that overexpress the proinflammatory enzymes COX-2 and 5-LOX (Western Blot), exceeding the activity of the drug Celecoxib.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrazolesAntineoplastic AgentsDrug DesignCyclooxygenase 2 InhibitorsLipoxygenase InhibitorsArachidonate 5-LipoxygenaseOrganometallic CompoundsHumansStructure-Activity RelationshipCyclooxygenase 2Cell Line, TumorFemaleMolecular Dynamics SimulationDrug Screening Assays, Antitumor

Substanzen

PyrazolesAntineoplastic AgentsCyclooxygenase 2 InhibitorsLipoxygenase InhibitorsCyclooxygenase 2Arachidonate 5-LipoxygenaseOrganometallic Compounds

Autor:innen und Institutionen

  • Departamento de Ciencias del Ambiente, Universidad de Santiago de Chile, Santiago 9170022, Chile.
  • Faculty of Chemistry and Biochemistry, Inorganic Chemistry I - Bioinorganic Chemistry, Ruhr-Universität Bochum, Universitätsstrasse 150, Bochum 44780, Germany.
  • Department of Chemistry, X-ray Crystallography Facility, University of Zürich, Zürich 8057, Switzerland.
  • Chimie ParisTech, PSL University, Centre National de la Recherche Scientifique (CNRS), Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, Paris 75005, France.
  • Departamento Química de los Materiales, Universidad de Santiago de Chile, Santiago 9170022, Chile.
  • Instituto de Química, Facultad de Ciencias, Universidad de Valparaíso, Valparaíso 2360102, Chile.

ORCID-Profile: Elizabeth Navarrete, Tomás Cáceres M, Olivier Blacque, Fernando Godoy, Gilles Gasser, Erick Flores

Förderung

  • Departamento de Investigaciones Cient?ficas y Tecnol?gicas, Universidad de Santiago de Chile
  • Fondo Nacional de Desarrollo Cient?fico y Tecnol?gico

Zitieren

APA

Navarrete, E., Cáceres M, T., Morales, P., Muñoz-Osses, M., Blacque, O., Mesdom, P., Cariou, K., Godoy, F., Gasser, G., Flores, E., & Mascayano, C. (2026). Design, Synthesis, and Evaluation of Organic and Organometallic Pyrazoline Derivatives as Selective Dual COX-2/5-LOX Inhibitors and Potential Anticancer Agents. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02815

Vancouver

Navarrete E, Cáceres M T, Morales P, Muñoz-Osses M, Blacque O, Mesdom P, et al. Design, Synthesis, and Evaluation of Organic and Organometallic Pyrazoline Derivatives as Selective Dual COX-2/5-LOX Inhibitors and Potential Anticancer Agents. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c02815

BibTeX
@article{Navarrete2026,
  author = {Navarrete, Elizabeth and Cáceres M, Tomás and Morales, Pilar and Muñoz-Osses, Michelle and Blacque, Olivier and Mesdom, Pierre and Cariou, Kevin and Godoy, Fernando and Gasser, Gilles and Flores, Erick and Mascayano, Carolina},
  title = {Design, Synthesis, and Evaluation of Organic and Organometallic Pyrazoline Derivatives as Selective Dual COX-2/5-LOX Inhibitors and Potential Anticancer Agents},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.5c02815}
}
Kostenlos starten →